Skip to main content
. Author manuscript; available in PMC: 2013 Mar 16.
Published in final edited form as: Vaccine. 2012 Feb 1;30(13):2309–2314. doi: 10.1016/j.vaccine.2012.01.058

Table 3.

Geometric mean titer and 95% confidence for month 7 HPV antibody levels of 182 FSWs by baseline serostatus

Total Baseline Seronegative Baseline Seropositive p-value*
N GMT (95%CI) N GMT (95%CI) N GMT (95%CI)
HPV6 182 1069.8 (895.5–1278.1) 77 658 (536.3–807.3) 105 1528 (1189.3–1963.1) <0.01
HPV11 182 761.1 (656.4–882.6) 141 606.7 (535–688) 41 1660.3 (1082.7–2546.1) <0.01
HPV16 182 2952.5 (2604–3347.7) 105 2641.5 (2211–3156) 77 3436.4 (2900–4072.4) 0.04
HPV18 182 565.6 (491.9–650.4) 158 504.6 (437.5–582) 24 1198.3 (808.4–1776.4) <0.01
*

t-test on log titers

All GMT values are in mMu